OCD affects approximately 1-3% of the population and often begins in childhood or adolescence. While OCD was previously considered untreatable, advances in the past few decades have led to effective evidence-based treatments. Key Facts: Glutamatergic medications like memantine, ketamine, and N-acetylcysteine have shown preliminary evidence of efficacy in small trials, but larger studies have been …
A new study provides promising evidence that delivering transcranial direct current stimulation (tDCS) remotely in people’s homes could be an effective treatment approach for major depressive disorder. The key facts are: tDCS is a form of non-invasive brain stimulation that uses electrical currents to modulate activity in targeted brain regions. When applied to the left …
Deep brain stimulation using focused ultrasound leads to rapid remission of severe depression in breakthrough patient case study. Key Facts: Focused ultrasound targeted and suppressed hyperactive areas linked to depression. Stimulation lasted just 64 minutes yet caused depression remission for over 6 weeks. Approach is noninvasive and precisely targeted with no side effects observed. Technology …
Most pharmacological-based treatments for depression aim to increase levels of various neurotransmitters, particularly serotonin (5-HT). It is thought that approximately 2 out of 3 individuals that seek treatment with standard antidepressants such as SSRIs and SNRIs are able to attain therapeutic relief. For a certain percentage of these individuals, the benefits of using pharmaceutical interventions …